
Saturday, March 30, 2024 11:08:39 AM
The better position Sintx is in the more aggressive the market manipulation has been. An investigation needs to occur. The tech is too important. Every offering is naked shorted and this is easily confirmed in the SECs fail to deliver data. Millions upon millions have been failed to deliver in regards to Sintx this year. This doesnt represent the total of shares naked shorted just what wasnt covered in a timely fashion.
20240201|829392604|SINT|696466|SINTX TECHNOLOGIES INC COM COM|0.15
20240202|829392604|SINT|5939951|SINTX TECHNOLOGIES INC COM COM|0.15
20240205|829392604|SINT|113856|SINTX TECHNOLOGIES INC COM COM|0.16
20240223|829392604|SINT|331948|SINTX TECHNOLOGIES INC COM COM|0.14
https://www.sec.gov/data/foiadocsfailsdatahtm
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Extra information on the status of a Si3n4 based hip implant:
Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies
Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422432/
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes

https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Sintx Technologies Announces Board Chairman Transition • GlobeNewswire Inc. • 03/17/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/13/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2025 03:46:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2025 01:30:29 PM
- SINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 02/26/2025 01:00:00 PM
- SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market • GlobeNewswire Inc. • 02/20/2025 11:15:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2025 11:10:05 AM
- This Healthcare Stock Rose Sharply On USPTO Issuance • AllPennyStocks.com • 02/19/2025 07:10:00 PM
- SINTX Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial • GlobeNewswire Inc. • 02/19/2025 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 10:08:19 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/14/2025 09:42:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2024 09:15:30 PM
- SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications • GlobeNewswire Inc. • 12/17/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2024 09:15:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 06:15:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/26/2024 11:10:12 AM
- SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment • GlobeNewswire Inc. • 11/21/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 10:13:22 PM
- SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer • GlobeNewswire Inc. • 11/19/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2024 11:15:16 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/15/2024 12:25:52 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/14/2024 09:15:08 PM
- SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 • GlobeNewswire Inc. • 11/14/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 08:50:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 08:30:16 PM
FEATURED 4Cable TV International, Inc. Unleashes Bold Strategy to Maximize Shareholder Value with close to 7.8 billion Dilutive Shares Eliminated • Mar 18, 2025 1:15 PM
FEATURED Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection • Mar 18, 2025 8:36 AM
FEATURED Xtreme One Entertainment Announces $1.5 Million Private Placement • Mar 18, 2025 12:00 AM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM